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Contractility
Ca2+ overloadSTIM1 plays a crucial role in Ca2+ homeostasis, particularly in replenishing the intracellular Ca2+ store
following its depletion. In cardiomyocytes, the Ca2+ content of the sarcoplasmic reticulum must be tightly
controlled to sustain contractile activity. The presence of STIM1 in cardiomyocytes suggests that it may
play a role in regulating the contraction of cardiomyocytes. The aim of the present study was to determine
how STIM1 participates in the regulation of cardiac contractility. Atomic force microscopy revealed that knocking
down STIM1 disrupts the contractility of cardiomyocyte-derived HL-1 cells. Ca2+ imaging also revealed that
knocking down STIM1 causes irregular spontaneous Ca2+ oscillations in HL-1 cells. Action potential recordings
further showed that knocking down STIM1 induces early and delayed afterdepolarizations. Knocking down
STIM1 increased the peak amplitude and current density of T-type voltage-dependent Ca2+ channels (T-VDCC)
and shifted the activation curve toward more negative membrane potentials in HL-1 cells. Biotinylation assays
revealed that knocking down STIM1 increased T-VDCC surface expression and co-immunoprecipitation assays
suggested that STIM1 directly regulates T-VDCC activity. Thus, STIM1 is a negative regulator of T-VDCC activity
and maintains a constant cardiac rhythm by preventing a Ca2+ overload that elicits arrhythmogenic events.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Ca2+ is central in the regulation of cardiac contractility [1]. Cardiac
contractility relies on the synergic action of L-type voltage-dependent
Ca2+ channel (L-VDCC) and cardiac ryanodine receptor (RyR2), which
provide Ca2+ through Ca2+-induced Ca2+ release (CICR) [2]. In
addition to this essential mechanism, another process known as store-
operated Ca2+ entry (SOCE), replenishes the sarcoplasmic reticulum
(SR), the main Ca2+ store of the cell. This process has been best charac-
terized in non-excitable cells, but has also been observed in excitable
cells. For example, SOCE has been shown to prevent skeletal muscle
fatigue by sustaining the Ca2+ store content of the SR [3]. SOCE has
also been shown to play a role in the development of cardiomyocytelar free Ca2+; AFM, atomic
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l rights reserved.hypertrophy [4,5]. However, there is no indication as yet that SOCE is di-
rectly involved in the contractile activity of cardiomyocytes. Stromal in-
teraction molecule 1 (STIM1) and Orai1 are the twomajor components
of SOCE [6,7]. STIM1 is a single-pass transmembrane protein located on
the SRwhere it serves as a Ca2+ sensor [8]. Upon store depletion, STIM1
detects a decrease in the SR Ca2+ concentration through its EF-hand
domain and forms punctae that move near the plasma membrane,
where it directly binds to and activates Orai1 [9–11]. Orai1 forms a
tetrameric Ca2+ channel at the plasma membrane [12]. Orai1 is the
pore-forming region of CRAC [13,14].
In cardiomyocytes, where the ﬂuctuation of the intracellular Ca2+
concentration leads to rhythmic contraction, the Ca2+ content of the
SR must be tightly controlled. Since STIM1 is expressed in HL-1 cells
[15] and acts as the Ca2+ sensor of the SR, it should participate in the
regulation of the contractile activity of cardiomyocytes. The aim of the
present study was thus to determine whether STIM1 is involved in
the regulation of cardiac contractility. Here, we show that knocking
down STIM1 causes a deregulation of both spontaneous contractions
and intracellular Ca2+ oscillations in HL-1 cells. Action potentials
are also perturbed when STIM1 expression is decreased, eliciting
arrhythmogenic events called delayed afterdepolarizations. We further
show that STIM1 physically interacts with T-VDCC to prevent an
increase in ICa,T density and negatively modulates T-VDCC activity. This
result is further conﬁrmed by an increase in T-VDCC surface expression
when STIM1 expression is decreased. Taken altogether, these results
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moderating T-VDCC activity.
2. Materials and methods
2.1. Materials
Claycomb medium, fetal bovine serum (FBS), ascorbic acid,
norepinephrine (NE), soybean trypsin inhibitor, ﬁbronectin, and
caffeine were purchased from Sigma-Aldrich (St. Louis, MO, USA).
Trypsin-EDTA 0.05% was from Wisent Inc. (St-Bruno, QC, Canada).
Penicillin/streptomycin, L-glutamine, Hepes, Lipofectamine 2000,
OptiMEM, and Block-it AlexaFluor Red Fluorescent Oligo were from
Invitrogen (Burlington, ON, Canada). Fura-2/AM was from Calbiochem
(La Jolla, CA, USA). Rabbit polyclonal anti-STIM1 antibody, mouse
monoclonal anti-actin antibody, and nitrocellulose membranes were
from Millipore (Temecula, CA, USA). Rabbit polyclonal anti-STIM2
antibody was from AbCam (Cambridge, MA, USA). Rabbit polyclonal
anti-CaV3.1 antibody was from Alomone Labs (Jerusalem, Israel).
Horseradish peroxidase-conjugated sheep anti-mouse and horseradish
peroxidase-conjugated donkey anti-rabbit antibodies were from
Amersham Biosciences. A/G PLUS-agarose beads were from Santa
Cruz Biotechnology (Santa Cruz, CA, USA). Sulfo-NHS-SS-Biotin and
streptavidin-agarose beads were from Pierce (Pierce Biotechnology,
Rockford, IL, USA). STIM1 siRNA and control siRNA (ON-TARGETplus
Control Pool) were from Dharmacon, Inc. (Lafayette, CO, USA). Unless
otherwise stated, all other reagents were from Sigma-Aldrich (Oakville,
ON, Canada) or Laboratoire MAT (Quebec City, QC, Canada).
2.2. Cell culture and transfection with siRNAs
The cardiomyocyte-derived HL-1 cell was used because it displays
spontaneous and rhythmic activities (contractions, Ca2+ oscillations
and electrical activity) and can be easily manipulated to gain a better
understanding of these activities at the cellular and molecular levels.
HL-1 cell line was kindly provided by William Claycomb (Louisiana
State University Medical Center, New Orleans, LA, USA) and was
cultured as previously described [16]. Brieﬂy, HL-1 cells were cultured
in Claycomb medium supplemented with 10% FBS in the presence of
2 mM L-glutamine, 100 μg/mL streptomycin, 100 U/mL penicillin, and
100 μM NE (prepared from a 10 mM stock solution in 30 mM ascorbic
acid) at 37 °C in a humidiﬁed 5% CO2 environment. HL-1 cells were
transiently transfected with siRNAs at a ﬁnal concentration of 50 nM
using Lipofectamine 2000 according to manufacturer's instructions.
siRNA transfection efﬁciency and the selection of transfected cells for
[Ca2+]i and contraction measurements were assessed using Block-it
AlexaFluor Red Fluorescent Oligo. siRNA transfection efﬁciency was
approximately 90%.
2.3. Co-immunoprecipitation and Western blotting
HL-1 cells were lysed with cold RIPA buffer containing 20 mM
Tris-HCl (pH 8.0), 150 mM NaCl, 1% Nonidet P40, 0.5% deoxycholate,
5 mM EDTA, 0.1% SDS, 1 μg/mL soybean trypsin inhibitor, 5 μg/mL
leupeptin, and 100 μM phenylmethylsulfonyl ﬂuoride for 20 min at
4 °C followed by 20 passages through a 20-gauge needle and 5 passages
through a 25-gauge needle. The cell lysate was centrifuged at 15,000 g
for 15 min to remove insolublematerials, and the protein concentration
in the supernatant was determined using the Bradford method. The
supernatant was then incubated for 16 h at 4 °C with the indicated
antibody immobilized on protein A/G PLUS-agarose beads. The beads
were washed three times with solubilizing buffer and were heated
for 30 min at 60 °C in 2× Laemmli buffer containing 40 mg/mL of
dithiothreitol to denature the proteins. The proteinswere then resolved
by SDS-PAGE and were transferred to nitrocellulose membranes in a
buffer containing 25 mMTris-base, 200 mMglycine, and 20%methanol(pH ~8.2). After staining with Ponceau S, the blots were washed with
TBS-T and were incubated for 1 h at room temperature in 5% non-fat
skim milk. To detect protein bands, the blots were incubated with
the indicated antibodies for 16 h at 4 °C followed by HRP-coupled
anti-antibodies for 90 min at room temperature, and then with an
enhanced chemiluminescence reagent.
2.4. Biotinylation of cell surface proteins
To biotinylate cell surface proteins, we used the method described
by Cayouette et al. [17]. Brieﬂy, siRNA-transfected HL-1 cells grown
for 48–72 h in 6-well plates were washed with ice-cold PBS
containing 0.9 mM CaCl2 and 1 mM MgCl2 (PBS with Ca2+/Mg2+).
The cells were placed on ice and washed twice with ice-cold PBS
and then incubated for 90 min at 4 °C with 3 mg/mL of Sulfo-NHS-
SS-Biotin in PBS with Ca2+/Mg2+. The biotinylation reaction was
terminated by washing the cells three times with ice-cold PBS
containing 10 mM glycine. The cells were then lysed with 400 μL of
ice-cold RIPA buffer for 30 min at 4 °C followed by 20 passages through
a 20-gauge needle and 5 passages through a 25-gauge needle.
The cell extracts were cleared by centrifugation and added to 75 μL
of streptavidin-agarose beads and incubated for 16 h at 4 °C.
The biotin-streptavidin-agarose complexeswere harvested by centrifuga-
tion and washed three times with RIPA buffer. The beads were then
resuspended in 2× Laemmli buffer containing 40 mg/mL of dithiothreitol
and incubated at 60 °C for 30 min before SDS-PAGE separation and
immunoblotting.
2.5. Measurement of intracellular free Ca2+, [Ca2+]i
The method described by Zhu et al. was used to measure [Ca2+]i
[18]. Brieﬂy, HL-1 cells were grown on coverslips pre-coated with
gelatin/ﬁbronectin. After a 48–72 h transfection, the coverslips were
washed twice with Hepes buffered saline solution (HBSS (in mM):
120 NaCl, 5.3 KCl, 0.8 MgSO4, 10 glucose, 1.8 CaCl2, 20 Hepes,
pH 7.4) and were loaded with fura-2/AM (4 μM in HBSS) for 20 min
at room temperature in the dark. After washing and de-esterifying
in fresh HBSS for 20 min at room temperature, the coverslips were
inserted in a circular open-bottom chamber and were placed on
the stage of an Olympus IX71 microscope (Olympus Canada Inc.,
Markham, ON, Canada) equipped with a Lambda-DG-4 illuminator
(Sutter Instrument Company, Novato, CA, USA). [Ca2+]i in selected
fura2-loaded cells (40 to 50 cells/coverslip) was measured by ﬂuores-
cence videomicroscopy at room temperature using alternating excita-
tion wavelengths of 340 nm (26 nm bandpass) and 387 nm (11 nm
bandpass). Emitted ﬂuorescence was monitored at 510 nm (84 nm
bandpass) through a 415–570 nm dichroic mirror. Fluorescence
intensity was monitored using an Evolve™ EMCCD camera (Photo-
metrics, Tucson, AZ, USA). The images were digitized and ana-
lyzed using MetaFluor software (Universal Imaging Corporation,
Downingtown, PA, USA). Free [Ca2+]i was calculated from the
340/387 ﬂuorescence ratios using the method of Grynkiewicz
et al. [19]. All reagents were diluted to their ﬁnal concentrations
in HBSS and were applied to the cells by surface perfusion.
Ca2+-free HBSS was supplemented with 0.5 mM EGTA to chelate
any remaining extracellular Ca2+.
2.6. Measurement of contractility by atomic force microscopy (AFM)
The method described by Domke et al. was used to measure HL-1
cells contractility [20]. Brieﬂy, cells were grown on 60-mm-diameter
dishes pre-coatedwith gelatin/ﬁbronectin. After a 48–72 h transfection,
the dishes were placed in a custom-made AFM setup mounted over an
inverted microscope (Motic, Richmond, BC, Canada), which made it
possible to observe beating cells and position the AFM tip on top of
them. The system was comprised of a Z-piezo scanner (P753.21C,
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sensor with a nominal closed-loop resolution of 0.1 nm, a piezoelectric
XY positioner (PXY 200/28 motion x, y 200 μM, Piezosystem Jena, MA,
USA), and a 635-nm laser source (OZ-2000 series, OZ Optics, USA) to
detect cantilever deﬂection. The setup was installed in an acoustic
and vibration isolation box at a controlled temperature at 37 °C. All
experiments were performed with non-conductive silicon nitride
cantilevers (Veeco, Camarillo, CA, USA), with a nominal force constant
of 0.01 N/m, calibrated using the thermal noise method [21,22].
Data was analyzed using Igor ProWaveMetrics software (Lake Oswego,
OR, USA).
2.7. Electrophysiology
Action potentials were recorded at room temperature using the
current clamp technique. The extracellular solution contained (in mM):
120 NaCl, 5.3 KCl, 0.8 MgSO4, 10 glucose, 1.8 CaCl2, and 20 Hepes100
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Fig. 2. Knocking down STIM1 perturbs the rate of contraction of HL-1 cells. (A) Representative trace showing the contraction of a cell transfected with siCTL and the corresponding
autocorrelation analysis. (B) Representative trace showing the contraction of a cell transfected with siSTIM1 and the corresponding autocorrelation analysis. The stars indicate the
rhythmicity index (RI) value for each trace. (C, D) Summarized data showing the mean contraction periods (C) and the mean RI (D) in control cells (n = 37 cells) and in cells
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All values are expressed asmeans ± S.D., and statistical signiﬁcance
was tested using an unpaired Student's t-test. P ≤ 0.05 was considered
statistically signiﬁcant. The mean periods and rhythmicity index (RI)
were determined for each cell using an autocorrelation analysis as
described by Levine et al. [23] with the Perl Statistics-Autocorrelation
module (http://www.cpan.org) or ClampFit program (Molecular
Devices Inc., Sunnyvale, CA, USA). The RI has been previously used
to describe rhythm strength in studies on rhythmic Ca2+ oscillations
in cardiac pacemaker cells [24].
3. Results
3.1. STIM1 is expressed and controls the ryanodine-sensitive Ca2+ pool
in HL-1 cells
The involvement of endogenous STIM1 in the cellular Ca2+
homeostasis of HL-1 cells was investigated by silencing its expression
with an siRNA speciﬁc for STIM1 mRNA. Fig. 1A shows that STIM1 is
expressed in HL-1 cells. The transfection of HL-1 cells with an siRNA
speciﬁc for STIM1 (siSTIM1) decreased its expression to 31.2 ± 3.7%of that of cells transfected with a control siRNA (siCTL) (Fig. 1A).
The expression of STIM2, a closely related family member, was un-
affected by the transfection of siSTIM1 (Fig. 1B). Since STIM1 is
known to be an SR Ca2+ sensor, we ﬁrst investigatedwhether knocking
down STIM1 would affect the intracellular Ca2+ store of HL-1 cells. The
Ca2+ content of the SR was evaluated by releasing the ryanodine-
sensitive Ca2+pool using 10 mMcaffeine in the absence of extracellular
Ca2+. Fig. 1C shows mean traces of caffeine-induced Ca2+ release in
cells transfected with siCTL (solid line) or siSTIM1 (dashed line).
Caffeine-induced Ca2+ release was signiﬁcantly higher in siSTIM1-
transfected cells (527 ± 78 nM) than in control cells (353 ± 72 nM)
(Fig. 1D). We veriﬁed that the transfection of an unspeciﬁc siRNA did
not affect the caffeine-induced Ca2+ release in HL-1 cells (see Supple-
mental data Fig. 1). These results suggested that knocking down
STIM1 in HL-1 cells increases the ryanodine-sensitive Ca2+ pool of
the SR.
3.2. Knocking down STIM1 perturbs the rate of contraction of HL-1 cells
The effect of STIM1 knockdown on the contractility of HL-1 cells
was evaluated using AFM in its force measurement mode. In this
experiment, the rhythmic contractions of a cluster of cells were
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Fig. 3. Knocking down STIM1 causes irregular spontaneous Ca2+ oscillations in HL-1 cells. (A) Representative trace showing spontaneous Ca2+ oscillations in a control cell and the
corresponding autocorrelation analysis. (B) Representative trace showing spontaneous Ca2+ oscillations in a cell transfected with siSTIM1 and the corresponding autocorrelation
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1298 N. Nguyen et al. / Biochimica et Biophysica Acta 1833 (2013) 1294–1303detected by recording the deﬂection of the cantilever (in nm) as a
function of time [20]. Fig. 2A shows typical contractions of HL-1 cells
transfected with siCTL and the autocorrelation analysis of the typical
trace. The contraction signal was regular, with a mean period of
483 ± 147 ms (Fig. 2C). Fig. 2B shows typical contractions of HL-1
cells transfected with siSTIM1 and the corresponding autocorrelation
analysis. Interestingly, the contraction signal was visually more irregu-
lar than control cells and yielded a mean period of 569 ± 171 ms
(Fig. 2C). The mean RI (which reﬂects the strength of rhythmicity and
is identiﬁed as the third peak on the correlogram) [23]was signiﬁcantly
lower in HL-1 cells transfected with siSTIM1 (0.31 ± 0.06) than in cells
transfected with siCTL (0.63 ± 0.15) (Fig. 2D). We veriﬁed that the
transfection of an unspeciﬁc siRNA did not affect the contractions of
HL-1 cells (see Supplemental data Fig. 2A-C). These results showed that
STIM1 is involved in the control of contraction rhythmicity in HL-1 cells.3.3. Knocking down STIM1 induces irregular spontaneous Ca2+ oscillations
in HL-1 cells
HL-1 cells display spontaneous Ca2+ oscillations under basal
conditions [16,25]. Since Ca2+ is the key component underlyingeach contraction, the effect of knocking down STIM1 on spontaneous
Ca2+ oscillations in HL-1 cells was evaluated. Fig. 3A shows typical
Ca2+ oscillations in a cell transfected with siCTL and the autocorrela-
tion analysis of the corresponding trace. The mean period of the Ca2+
oscillations in control cells was 2.1 ± 0.5 s (Fig. 3C) and the mean RI
was 0.57 ± 0.20 (Fig. 3D). Fig. 3B shows typical Ca2+ oscillations in a
cell transfected with siSTIM1 and the corresponding autocorrelation
analysis. Knocking down STIM1 slowed the Ca2+ oscillations to a
mean period of 3.2 ± 1.1 s (Fig. 3C). The rhythm became also more
irregular, with a mean RI of 0.14 ± 0.06 (Fig. 3D). We also veriﬁed
that the transfection of an unspeciﬁc siRNA did not affect Ca2+
oscillations in HL-1 cells (see Supplemental data Fig. 2D-F). These
results showed that STIM1 is involved in the rhythmicity of spontaneous
Ca2+ oscillations in HL-1 cells.3.4. Knocking down STIM1 increases ICa,T density and alters electrical
excitability
The perturbed rhythmicity of spontaneous Ca2+ oscillations may
inﬂuence the duration and the waveform of action potentials in
HL-1 cells. We thus investigated the effect of knocking down STIM1
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action potentials in control cells. The mean period was 1.6 ± 0.3 s and
the mean RI was 0.79 ± 0.17 (Fig. 4C and D). In cells transfected with
siSTIM1, arrhythmogenic events such as delayed afterdepolarizations
were observed (as indicated by arrows in Fig. 4B). In these cells,
the mean period was 1.9 ± 0.7 s and the mean RI was 0.33 ± 0.18
(Fig. 4C and D). The presence of delayed afterdepolarizations is
consistent with the increased ryanodine-sensitive Ca2+ pool observed
in Fig. 1C and D and indicates an SR Ca2+ overload.
To gain further insights into the molecular mechanism that is
perturbed when STIM1 is knocked down in HL-1 cells, we investigated
the electrophysiological properties of VDCC. ICa was elicited by consec-
utive 300-ms test pulses between –75 and +20 mV in 5-mV incre-
ments. Under these conditions, we recorded both Ca2+ currents: ICa,L
and ICa,T. However, ICa,L was present in only 15% of the cells used for
recordings, while ICa,T was the predominant Ca2+ current in these cells,
which is consistent with previous data from Xia et al. [26]. In cells
transfected with siCTL, the ICa,T activation threshold was−55 mV, with
amaximumpeak current at−20 mV (Fig. 5A and B). In cells transfected
with siSTIM1, the ICa,T activation threshold was −60 mV, and the
maximum peak current was reached at −25 mV. However, the peakICa,T density was 25% higher in cells transfected with siSTIM1
(−16.9 ± 2.0 pA/pF) than in control cells (−12.7 ± 1.5 pA/pF)
(Fig. 5B). To obtain the voltage dependence of activation, we normal-
ized the conductance (G) of the current at eachpotential to themaximal
conductance (Gmax) obtained from the slope of a linear regression ﬁt to
the linear portion of the I/V relationship. Fig. 5C shows that knocking
down STIM1 signiﬁcantly shifted the activation curve of ICa,T toward
more negative potentials, indicating that the current activates at more
hyperpolarized potentials. The mean values of half-activation potential
(V1/2) were −33.4 ± 0.2 mV and −39.0 ± 0.2 mV for control cells
and cells transfected with siSTIM1, respectively.
To further investigate the mechanism involved in the increased ICa,T
density following STIM1 knockdown, we measured the availability of
T-VDCC at different voltages (steady-state inactivation). ICa,T inactiva-
tion was evaluated by using the standard two-pulse protocol consisting
of 300-ms preconditioning pulses between−90 and−25 mV in 5-mV
increments, followed by a test pulse to +10 mV (as described in
Fig. 5D). The inactivation curves of control and siSTIM1 cells (Fig. 5E)
were identical, indicating that knocking down STIM1 did not affect
the availability of T-VDCC. The mean values of half-inactivation po-
tential were −49.3 ± 0.1 mV for control cells and −49.5 ± 0.2 mV
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increase in ICa,T density is due to an increased expression of T-VDCC
rather than changes in its availability. Altogether, these results showed
that STIM1 negatively modulates T-VDCC channel activity.
3.5. Knocking down STIM1 increases ICa,T window current
The overlap between the ICa,T steady-state activation and inactiva-
tion curves delimits a region called “window current”. In this region,
the channel population dynamically equilibrates among closed, open,
and inactivated states, resulting in a steady-state leak current [27]. We
hypothesized that an increase in the Ca2+ window current following
STIM1 knockdown may be involved in the SR Ca2+ overload. We
found that the negative shift in the activation curve observed in cells
transfected with siSTIM1 substantially increased the ICa,T window
current, which provides support for this hypothesis (Fig. 6A). The ICa,T
window current (Iw) was obtained by multiplying the conductance of
the current (Gmax) at any given electromotive force (V-ECa) by the
activation and inactivationmid-potentials (h∞ · m∞) using the Hodgkin
and Huxley equation: Gmax · h∞ · m∞ · (V − Erev) [28]. Fig. 6B shows
that Iw increased 3-fold in cells transfected with siSTIM1 (open circles)
compared to control cells (full circles). These results were consistent
with an increase in the ICa,T leak (window) current contributing to a
Ca2+ overload in siSTIM1 cells. It also indicated that STIM1 contributes
to the regulation of SR Ca2+ loading indirectly bymodulating the activity
of T-type calcium channels.3.6. Knocking down STIM1 increases T-VDCC surface expression
To determinewhether the increase in T-VDCC activity was due to an
increase in T-VDCC surface expression, we veriﬁed the effect of STIM1
knockdown on CaV3.1 levels, a T-VDCC isoform expressed at the plasma
membrane of HL-1 cells [26,29]. Cell surface proteins were selectively
biotinylated with the membrane-impermeable amino reagent sulfo-
NHS-SS-biotin. The proteins were then solubilized and incubated
with streptavidin-agarose beads before immunoblotting with an anti-
CaV3.1 antibody. Fig. 6C shows that surface expression of CaV3.1 was
increased by 1.8 ± 0.4 fold (n = 3 independent experiments) when
STIM1 expression was decreased. Since the total expression of CaV3.1
was unchanged, this result suggests a redistribution of CaV3.1 from an
intracellular compartment to the cell surface. This result is in agreement
with our previous data showing that STIM1 negatively regulates
T-VDCC activity by preventing the surface expression of the channel.
3.7. STIM1 interacts with CaV3.1 in HL-1 cells
We performed a co-immunoprecipitation assay to verify whether
STIM1 physically interacts with CaV3.1. Fig. 6D shows that STIM1 was
detected in the immunoprecipitate of CaV3.1 and inversely, CaV3.1
was detected in the immunoprecipitate of STIM1. On the other hand,
STIM1 or CaV3.1 were not detected in the immunoprecipitate when
an unrelated rabbit anti-IgG antibody (negative control) was used.
These results suggested that STIM1 physically interacts with T-VDCC.
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The aim of the present study was to investigate the involvement of
STIM1 in the regulation of cardiac contractility. Our results showed
that STIM1 is expressed in HL-1 cells, a murine atrial-derived cell
line that displays spontaneous Ca2+ oscillations and contractions
[16,25]. Recent reports have also shown that STIM1 is expressed
in HL-1 cells [15] and other types of cardiomyocytes [4,5,30,31].
These studies have focused on the essential role of STIM1 in the
Ca2+-dependent development of cardiac hypertrophy. However, the
role of STIM1 in the spontaneous activity and the contractile function
of cardiomyocytes are unknown. In non-excitable cells, STIM1
normally acts as an activator of Orai1 and some TRPC channels when
the Ca2+ store is depleted [32–34]. A knockdown of STIM1 results in a
decrease in SOCE [6,8]. However, our results pointed to an unexpected
function of STIM1 inHL-1 cells. Indeed,we showed that STIM1dampens
the activity of T-VDCC to prevent an excessive Ca2+ entry resulting in
an SR Ca2+ overload that can lead to arrhythmogenic events. This is a
new regulation pathway for the control of Ca2+ homeostasis leading
to rhythmic contractions in beating HL-1 cells. These ﬁndings were
further conﬁrmed by our observation that knocking down STIM1
induces arrhythmogenic events such as delayed afterdepolarizations,
which are known to occur under conditions of SR Ca2+ overload
[35,36]. The increase in the caffeine-induced Ca2+ release observed in
cells transfected with siSTIM1 was also consistent with an SR Ca2+
overload. At rest, the SR Ca2+ content depends on the balance between
Ca2+ uptake by the SERCA pump and efﬂux of Ca2+ mostly through
cardiac ryanodine receptors (RyR2). The activity of SERCA depends on
various factors such as the [Ca2+]i. A higher [Ca2+]i will enhance the
activity of SERCA [37]. We showed that the activity of T-VDCC isenhanced in STIM1-knocked down cells, causing a greater Ca2+ inﬂux
into the cells. Under this circumstance, we expect that the SERCA
pump activity would also be increased resulting in an excess of Ca2+
in the SR. A Ca2+ overload usually gives rise to spontaneous SR Ca2+
release through the RyR2, often referred to as Ca2+ sparks [38]. Ca2+
sparks participate in the initiation and propagation of Ca2+ waves
in cardiomyocytes, ultimately leading to the extrusion of Ca2+ via
the Na+/Ca2+ exchanger and the generation of a transient inward
current that can lead to early and delayed afterdepolarizations [39,40].
Importantly, it is well established that T-VDCC participates in the cardiac
automaticity of pacemaker and latent pacemaker cells [41,42]. In HL-1
cells, spontaneous activity has been attributed to both intracellular
Ca2+ release and sarcolemmal ionic currents [43]. Recent studies have
suggested that spontaneous Ca2+ release from the SR is an important
mechanism of automaticity [44,45]. Indeed, spontaneous rhythmic
Ca2+ release from the SR in pacemaker cells results in an increase
in [Ca2+]i, which in turn activates INCX and leads to membrane depolar-
ization [46,47]. To date, no clear mechanism has been discovered
that shows how T-VDCC regulates cardiac automaticity. However, the
present study showed that STIM1 is a key element in a previously
unknown mechanism for regulating T-VDCC activity, suggesting that
it may contribute to modulate the cardiac rhythmicity and excitability
of native pacemaker cells.
We found that HL-1 cells display mostly ICa,T, which is in agreement
with previous reports showing that the predominant Ca2+ current in
HL-1 cells is mediated by T-VDCC [26]. Two previous studies reported
that the depletion of the Ca2+ store negatively regulates L-VDCC
activity in A7r5 cells, T-lymphocytes, and primary cortical neurons
[48,49]. The overexpression of STIM1 or the expression of a STIM1
EF-hand mutant unable to detect Ca2+ in the SR both reduced the
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STIM1 directly interacts with CaV1.2 and inhibits its activity. While our
results do not rule out the involvement of L-VDCC in the contraction of
HL-1 cells, they strongly suggest that STIM1 directly regulates T-VDCC.
Indeed, we showed that STIM1 co-immunoprecipitates with T-VDCC
and that knocking down STIM1 increases ICa,T density without affecting
its availability, suggesting that STIM1 may play a role in the expression
of T-VDCC. To corroborate this hypothesis, we showed that knocking
down STIM1 also increased T-VDCC surface expression. Further studies
are needed to evaluate the exact role of STIM1 in T-VDCC trafﬁcking.
Our study, together with the studies of Park et al. [48] and Wang et al.
[49], describe a new role for STIM1 in excitable cells. Contrary to its
main role in non-excitable cells which is to detect Ca2+ levels in the
ER in order to replenish it, in excitable cells STIM1 physically interacts
with VDCC to prevent an excessive Ca2+ entry into the cell by reducing
VDCC surface expression. Further studies are needed to determine
whether the exact mechanism underlying the cell surface expression
of T-VDCC is dependent on the Ca2+ content of the SR or on the expres-
sion and localization of STIM1. Thus, in atrial myocytes, in which the
SERCA pump is abundantly expressed, the negative regulation of Ca2+
entry may be an important mechanism for preventing Ca2+ overload
and arrhythmogenic events. This idea is supported by our results showing
that caffeine-induced Ca2+ release was signiﬁcantly higher in cells
transfected with siSTIM1.
In conclusion, our results suggest that STIM1 negatively regulates
T-VDCC activity in HL-1 cells by reducing its cell surface expression,
thus preventing an SR Ca2+ overload that can elicit arrhythmogenic
events.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bbamcr.2013.02.027.
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